OncoRes Medical

OncoRes Medical is an Australian medical device company developing an innovative handheld imaging probe designed to improve the accuracy of breast-conserving surgery. The company's technology utilizes Optical Coherence Elastography (OCE) to provide surgeons with real-time, high-resolution micro-scale maps of tissue stiffness, helping to identify residual cancer cells that are often missed by touch or sight. By enabling more precise tumor margin assessment, OncoRes aims to significantly reduce the need for repeat surgeries, which currently affect a large percentage of breast cancer patients. The platform has potential applications across various solid tumor surgeries where clear margins are critical for patient outcomes. The company has received FDA Breakthrough Device Designation for its lead imaging system.